Introduction
The global diabetic foot ulcer (DFU) treatment market size is expected to around USD 7.4 billion by 2026, this market is foreseen to develop with 8.4% CAGR during the forecast time period.
Market Dynamics Rising predominance of diabetes and quickly developing geriatric populace worldwide are among the essential development stimulants for DFU treatment market. Diabetic foot ulcer is one of the significant confusions of diabetes mellitus, which shapes a noteworthy normal for diabetic foot.
Recuperating of wounds is ordinarily an innate mechanism. Be that as it may, certain metabolic issue, for example, diabetes mellitus defers run of the mill pace of wound mending process. Diabetic foot ulcers are most usually caused by aggravated or injured feet, nerve harm, poor circulation, and high blood sugar (hyperglycemia).Unusual swelling, irritation, redness, and stenches on one or the two feet are regular beginning symptoms of foot ulcer.
Market Insights
Wound care dressings have been additionally segmented into hydrocolloid dressings, hydrofiber dressings, alginate dressings, film dressing, foam dressings, surgical dressings, and hydrogel dressings. Foam dressings were at the forefront among various kinds of wound consideration dressings in 2018. Therapy gadgets have been bifurcated into negative pressure wound therapy or treatment and ultrasound treatment. Spiraling acceptance of medicinal gadgets for an adequate, better focused on, and more secure treatment of patients is probably going to make a rise in the demand for diabetic foot ulcer treatment gadgets.
Among various ulcer types, neuro-ischemic ulcers drove the market in 2018 with over 50.5% piece of the pie because of higher patient populace experiencing the ulcer type all around. North America spoke to the biggest offer in the worldwide market in 2017 inferable from rising commonness of diabetes, developing geriatric accomplice, expanded interest in R&D of novel treatments, and developed healthcare facilities.
Market Segmentation
Market By Treatment
- Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
- Biologics
- Growth Factors
- Skin Grafts
- Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
- Antibiotic Medications
- Others
Market By Ulcer Type
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
Market By Geography
- North America
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Regional Insights
Europe held the second biggest offer in the market, trailed by Asia Pacific. APAC will display the most elevated CAGR during the coming years. Expanding commonness of diabetes and an extensive geriatric populace base in the two India and China are supporting the development of the provincial market. This can likewise be credited to expanded reception and ideal enactment in developed economies, for example, Japan and Australia. North America drove the market in 2018. Rising partner of diabetic patients and satisfactory medicinal services offices in the region are key components in charge of the development of the provincial market. Long R&D and approval cycles are required because of capital-concentrated nature in North America, which go about as a hindrance for the development of the market in the region. Notwithstanding, rising appropriation of novel biologics and wound consideration gadgets for treatment of these ulcers are adding to the predominance of North America.
Market Participants
Few of the main businesses present in the global Diabetic foot ulcer (DFU) treatment market are BSN Medical GMBH, ConvaTec, Inc.; Molnlycke Health Care AB; Acelity L.P. Inc.; Organogenesis, Inc.; 3M Healthcare; Medtronic Plc.; Coloplast A/S; Medline Industries, Inc.; Smith & Nephew Plc.; and B. Braun Melsungen AG.
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Diabetic Foot Ulcer (DFU) Treatment
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Diabetic Foot Ulcer (DFU) Treatment Market By Treatment
1.2.2.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison By Treatment (2015-2026)
1.2.2.2. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share By Treatment in 2017
1.2.2.3. Wound Care Dressings
1.2.2.4. Biologics
1.2.2.5. Therapy Devices
1.2.2.6. Antibiotic Medications
1.2.2.7. Others
1.2.3. Diabetic Foot Ulcer (DFU) Treatment Market By Ulcer Type
1.2.3.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison By Ulcer Type (2015-2026)
1.2.3.2. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share By Ulcer Type in 2017
1.2.3.3. Neuropathic Ulcers
1.2.3.4. Ischemic Ulcers
1.2.3.5. Neuro-ischemic Ulcers
1.2.3.6. Others
1.2.4. Diabetic Foot Ulcer (DFU) Treatment Market by Geography
1.2.4.1. Global Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Diabetic Foot Ulcer (DFU) Treatment Major Manufacturers in 2017
CHAPTER 4. DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY TREATMENT
4.1. Global Diabetic Foot Ulcer (DFU) Treatment Revenue By Treatment
4.2. Wound Care Dressings
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Biologics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Therapy Devices
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Antibiotic Medications
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY ULCER TYPE
5.1. Global Diabetic Foot Ulcer (DFU) Treatment Revenue By Ulcer Type
5.2. Neuropathic Ulcers
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Ischemic Ulcers
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Neuro-ischemic Ulcers
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NORTH AMERICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
6.1. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 7. EUROPE DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
7.1. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
8.1. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 9. LATIN AMERICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
9.1. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 10. MIDDLE EAST DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
10.1. Middle East Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 11. AFRICA DIABETIC FOOT ULCER (DFU) TREATMENT MARKET BY COUNTRY
11.1. Africa Diabetic Foot Ulcer (DFU) Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Diabetic Foot Ulcer (DFU) Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Treatment, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Ulcer Type, 2015 - 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. BSN Medical GMBH
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. ConvaTec, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Molnlycke Health Care AB
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Acelity L.P. Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Organogenesis, Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. 3M Healthcare
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Medtronic Plc.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Coloplast A/S
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Medline Industries, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Smith & Nephew Plc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. B. Braun Melsungen AG.
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope